Who are Ciclopirox Olamine Oral's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ciclopirox-olamine-oral.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Ciclopirox Olamine Oral — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ciclopirox Olamine Oral (Ciclopirox Olamine Oral) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Broad-spectrum antifungal. Area: Infectious Disease / Dermatology.

phase 3 Broad-spectrum antifungal Fungal cytochrome P450 enzymes (iron/aluminum chelation) Infectious Disease / Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Ciclopirox Olamine Oral (Ciclopirox Olamine Oral) — Atlas Molecular Pharma. Ciclopirox olamine is a broad-spectrum antifungal agent that inhibits fungal cytochrome P450 enzymes and disrupts fungal cell membrane integrity.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ciclopirox Olamine Oral TARGET	Ciclopirox Olamine Oral	Atlas Molecular Pharma	phase 3	Broad-spectrum antifungal	Fungal cytochrome P450 enzymes (iron/aluminum chelation)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Broad-spectrum antifungal class)

Atlas Molecular Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ciclopirox Olamine Oral — Competitive Intelligence Brief. https://druglandscape.com/ci/ciclopirox-olamine-oral. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab